Surgery of small hepatocellular carcinoma. Analysis of 144 cases

Open Access
Publisher Website
Google Scholar
Abstract
A long‐term follow‐up study of 144 cases with surgically and pathologically proved small hepatocellular carcinoma (±5 cm) from 1967 to 1987 is reported. One hundred eight cases (75.0%) were detected by alpha‐fetoprotein serosurvey and/or ultrasonography mainly in a high‐risk population; 129 cases (89.6%) coexisted with cirrhosis. Resection was done in 132 cases (91.7%) with three (2.3%) operative deaths; cryosurgery, laser vaporization, and hepatic arterial chemotherapy were used in the rest. Limited resection was done in 67.4% of resections. Reresection of subclinical recurrence or solitary pulmonary metastasis was done in 21 cases. The 5‐year and 10‐year survival rates were 67.9% and 53.4% in the resection group but zero in the nonresection group. Survival was correlated negatively with tumor size, 5‐year survival after resection was 84.6% in tumors < 2 cm but 59.5% in tumors of 4.1 to 5 cm. The increase of resectability and reresection resulted in marked improved of 5‐year survival from 43.5% in 1973 to 1977 to 63.3% in 1978 to 1982 in the entire series. No significant difference was found between survival of limited resection and lobectomy. Resection may be the modality of choice for treatment of small hepatocellular carcinomas with compensated liver function. Limited resection instead of lobectomy was the key to increased resectability and decreased operative mortality in cirrhotic livers. Reresection of subclinical recurrence was important to prolong survival further.